The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preclinical Imaging Market Research Report 2024
Synopsis
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
The global Preclinical Imaging market was valued at US$ 1887.9 million in 2023 and is anticipated to reach US$ 3021.2 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
In 2018, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2018 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries.
This report aims to provide a comprehensive presentation of the global market for Preclinical Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Imaging.
Report Scope
The Preclinical Imaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Imaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perkinelmer
Bruker
Fujifilm
Mediso
Milabs
MR Solutions
Aspect Imaging
Li-Cor Biosciences
Trifoil Imaging
Miltenyi Biotec
Segment by Type
Optical Imaging Systems
Nuclear Imaging Systems
Micro-MRI Systems
Micro-Ultrasound Systems
Micro-CT Systems
Preclinical Photoacoustic Imaging Systems
Preclinical Magnetic Particle Imaging (MPI) Systems
Segment by Application
Hospitals
Diagnostics Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preclinical Imaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preclinical Imaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations.
The global Preclinical Imaging market was valued at US$ 1887.9 million in 2023 and is anticipated to reach US$ 3021.2 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
In 2018, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2018 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries.
This report aims to provide a comprehensive presentation of the global market for Preclinical Imaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preclinical Imaging.
Report Scope
The Preclinical Imaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Preclinical Imaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Preclinical Imaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perkinelmer
Bruker
Fujifilm
Mediso
Milabs
MR Solutions
Aspect Imaging
Li-Cor Biosciences
Trifoil Imaging
Miltenyi Biotec
Segment by Type
Optical Imaging Systems
Nuclear Imaging Systems
Micro-MRI Systems
Micro-Ultrasound Systems
Micro-CT Systems
Preclinical Photoacoustic Imaging Systems
Preclinical Magnetic Particle Imaging (MPI) Systems
Segment by Application
Hospitals
Diagnostics Centers
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Preclinical Imaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Preclinical Imaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Preclinical Imaging Market Overview
1.1 Product Overview and Scope of Preclinical Imaging
1.2 Preclinical Imaging Segment by Type
1.2.1 Global Preclinical Imaging Market Value Comparison by Type (2024-2030)
1.2.2 Optical Imaging Systems
1.2.3 Nuclear Imaging Systems
1.2.4 Micro-MRI Systems
1.2.5 Micro-Ultrasound Systems
1.2.6 Micro-CT Systems
1.2.7 Preclinical Photoacoustic Imaging Systems
1.2.8 Preclinical Magnetic Particle Imaging (MPI) Systems
1.3 Preclinical Imaging Segment by Application
1.3.1 Global Preclinical Imaging Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Others
1.4 Global Preclinical Imaging Market Size Estimates and Forecasts
1.4.1 Global Preclinical Imaging Revenue 2019-2030
1.4.2 Global Preclinical Imaging Sales 2019-2030
1.4.3 Global Preclinical Imaging Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Preclinical Imaging Market Competition by Manufacturers
2.1 Global Preclinical Imaging Sales Market Share by Manufacturers (2019-2024)
2.2 Global Preclinical Imaging Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Preclinical Imaging Average Price by Manufacturers (2019-2024)
2.4 Global Preclinical Imaging Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Preclinical Imaging, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Preclinical Imaging, Product Type & Application
2.7 Preclinical Imaging Market Competitive Situation and Trends
2.7.1 Preclinical Imaging Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Preclinical Imaging Players Market Share by Revenue
2.7.3 Global Preclinical Imaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Preclinical Imaging Retrospective Market Scenario by Region
3.1 Global Preclinical Imaging Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Preclinical Imaging Global Preclinical Imaging Sales by Region: 2019-2030
3.2.1 Global Preclinical Imaging Sales by Region: 2019-2024
3.2.2 Global Preclinical Imaging Sales by Region: 2025-2030
3.3 Global Preclinical Imaging Global Preclinical Imaging Revenue by Region: 2019-2030
3.3.1 Global Preclinical Imaging Revenue by Region: 2019-2024
3.3.2 Global Preclinical Imaging Revenue by Region: 2025-2030
3.4 North America Preclinical Imaging Market Facts & Figures by Country
3.4.1 North America Preclinical Imaging Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Preclinical Imaging Sales by Country (2019-2030)
3.4.3 North America Preclinical Imaging Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Preclinical Imaging Market Facts & Figures by Country
3.5.1 Europe Preclinical Imaging Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Preclinical Imaging Sales by Country (2019-2030)
3.5.3 Europe Preclinical Imaging Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Preclinical Imaging Market Facts & Figures by Country
3.6.1 Asia Pacific Preclinical Imaging Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Preclinical Imaging Sales by Country (2019-2030)
3.6.3 Asia Pacific Preclinical Imaging Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Preclinical Imaging Market Facts & Figures by Country
3.7.1 Latin America Preclinical Imaging Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Preclinical Imaging Sales by Country (2019-2030)
3.7.3 Latin America Preclinical Imaging Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Preclinical Imaging Market Facts & Figures by Country
3.8.1 Middle East and Africa Preclinical Imaging Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Preclinical Imaging Sales by Country (2019-2030)
3.8.3 Middle East and Africa Preclinical Imaging Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Preclinical Imaging Sales by Type (2019-2030)
4.1.1 Global Preclinical Imaging Sales by Type (2019-2024)
4.1.2 Global Preclinical Imaging Sales by Type (2025-2030)
4.1.3 Global Preclinical Imaging Sales Market Share by Type (2019-2030)
4.2 Global Preclinical Imaging Revenue by Type (2019-2030)
4.2.1 Global Preclinical Imaging Revenue by Type (2019-2024)
4.2.2 Global Preclinical Imaging Revenue by Type (2025-2030)
4.2.3 Global Preclinical Imaging Revenue Market Share by Type (2019-2030)
4.3 Global Preclinical Imaging Price by Type (2019-2030)
5 Segment by Application
5.1 Global Preclinical Imaging Sales by Application (2019-2030)
5.1.1 Global Preclinical Imaging Sales by Application (2019-2024)
5.1.2 Global Preclinical Imaging Sales by Application (2025-2030)
5.1.3 Global Preclinical Imaging Sales Market Share by Application (2019-2030)
5.2 Global Preclinical Imaging Revenue by Application (2019-2030)
5.2.1 Global Preclinical Imaging Revenue by Application (2019-2024)
5.2.2 Global Preclinical Imaging Revenue by Application (2025-2030)
5.2.3 Global Preclinical Imaging Revenue Market Share by Application (2019-2030)
5.3 Global Preclinical Imaging Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Perkinelmer
6.1.1 Perkinelmer Corporation Information
6.1.2 Perkinelmer Description and Business Overview
6.1.3 Perkinelmer Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Perkinelmer Preclinical Imaging Product Portfolio
6.1.5 Perkinelmer Recent Developments/Updates
6.2 Bruker
6.2.1 Bruker Corporation Information
6.2.2 Bruker Description and Business Overview
6.2.3 Bruker Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bruker Preclinical Imaging Product Portfolio
6.2.5 Bruker Recent Developments/Updates
6.3 Fujifilm
6.3.1 Fujifilm Corporation Information
6.3.2 Fujifilm Description and Business Overview
6.3.3 Fujifilm Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Fujifilm Preclinical Imaging Product Portfolio
6.3.5 Fujifilm Recent Developments/Updates
6.4 Mediso
6.4.1 Mediso Corporation Information
6.4.2 Mediso Description and Business Overview
6.4.3 Mediso Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mediso Preclinical Imaging Product Portfolio
6.4.5 Mediso Recent Developments/Updates
6.5 Milabs
6.5.1 Milabs Corporation Information
6.5.2 Milabs Description and Business Overview
6.5.3 Milabs Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Milabs Preclinical Imaging Product Portfolio
6.5.5 Milabs Recent Developments/Updates
6.6 MR Solutions
6.6.1 MR Solutions Corporation Information
6.6.2 MR Solutions Description and Business Overview
6.6.3 MR Solutions Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MR Solutions Preclinical Imaging Product Portfolio
6.6.5 MR Solutions Recent Developments/Updates
6.7 Aspect Imaging
6.6.1 Aspect Imaging Corporation Information
6.6.2 Aspect Imaging Description and Business Overview
6.6.3 Aspect Imaging Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aspect Imaging Preclinical Imaging Product Portfolio
6.7.5 Aspect Imaging Recent Developments/Updates
6.8 Li-Cor Biosciences
6.8.1 Li-Cor Biosciences Corporation Information
6.8.2 Li-Cor Biosciences Description and Business Overview
6.8.3 Li-Cor Biosciences Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Li-Cor Biosciences Preclinical Imaging Product Portfolio
6.8.5 Li-Cor Biosciences Recent Developments/Updates
6.9 Trifoil Imaging
6.9.1 Trifoil Imaging Corporation Information
6.9.2 Trifoil Imaging Description and Business Overview
6.9.3 Trifoil Imaging Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Trifoil Imaging Preclinical Imaging Product Portfolio
6.9.5 Trifoil Imaging Recent Developments/Updates
6.10 Miltenyi Biotec
6.10.1 Miltenyi Biotec Corporation Information
6.10.2 Miltenyi Biotec Description and Business Overview
6.10.3 Miltenyi Biotec Preclinical Imaging Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Miltenyi Biotec Preclinical Imaging Product Portfolio
6.10.5 Miltenyi Biotec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Preclinical Imaging Industry Chain Analysis
7.2 Preclinical Imaging Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Preclinical Imaging Production Mode & Process
7.4 Preclinical Imaging Sales and Marketing
7.4.1 Preclinical Imaging Sales Channels
7.4.2 Preclinical Imaging Distributors
7.5 Preclinical Imaging Customers
8 Preclinical Imaging Market Dynamics
8.1 Preclinical Imaging Industry Trends
8.2 Preclinical Imaging Market Drivers
8.3 Preclinical Imaging Market Challenges
8.4 Preclinical Imaging Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Preclinical Imaging Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Preclinical Imaging Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Preclinical Imaging Market Competitive Situation by Manufacturers in 2023
Table 4. Global Preclinical Imaging Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Preclinical Imaging Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Preclinical Imaging Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Preclinical Imaging Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Preclinical Imaging Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Preclinical Imaging, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Preclinical Imaging, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Preclinical Imaging, Product Type & Application
Table 12. Global Key Manufacturers of Preclinical Imaging, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Preclinical Imaging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preclinical Imaging as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Preclinical Imaging Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Preclinical Imaging Sales by Region (2019-2024) & (K Units)
Table 18. Global Preclinical Imaging Sales Market Share by Region (2019-2024)
Table 19. Global Preclinical Imaging Sales by Region (2025-2030) & (K Units)
Table 20. Global Preclinical Imaging Sales Market Share by Region (2025-2030)
Table 21. Global Preclinical Imaging Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Preclinical Imaging Revenue Market Share by Region (2019-2024)
Table 23. Global Preclinical Imaging Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Preclinical Imaging Revenue Market Share by Region (2025-2030)
Table 25. North America Preclinical Imaging Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Preclinical Imaging Sales by Country (2019-2024) & (K Units)
Table 27. North America Preclinical Imaging Sales by Country (2025-2030) & (K Units)
Table 28. North America Preclinical Imaging Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Preclinical Imaging Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Preclinical Imaging Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Preclinical Imaging Sales by Country (2019-2024) & (K Units)
Table 32. Europe Preclinical Imaging Sales by Country (2025-2030) & (K Units)
Table 33. Europe Preclinical Imaging Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Preclinical Imaging Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Preclinical Imaging Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Preclinical Imaging Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Preclinical Imaging Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Preclinical Imaging Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Preclinical Imaging Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Preclinical Imaging Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Preclinical Imaging Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Preclinical Imaging Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Preclinical Imaging Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Preclinical Imaging Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Preclinical Imaging Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Preclinical Imaging Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Preclinical Imaging Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Preclinical Imaging Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Preclinical Imaging Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Preclinical Imaging Sales (K Units) by Type (2019-2024)
Table 51. Global Preclinical Imaging Sales (K Units) by Type (2025-2030)
Table 52. Global Preclinical Imaging Sales Market Share by Type (2019-2024)
Table 53. Global Preclinical Imaging Sales Market Share by Type (2025-2030)
Table 54. Global Preclinical Imaging Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Preclinical Imaging Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Preclinical Imaging Revenue Market Share by Type (2019-2024)
Table 57. Global Preclinical Imaging Revenue Market Share by Type (2025-2030)
Table 58. Global Preclinical Imaging Price (USD/Unit) by Type (2019-2024)
Table 59. Global Preclinical Imaging Price (USD/Unit) by Type (2025-2030)
Table 60. Global Preclinical Imaging Sales (K Units) by Application (2019-2024)
Table 61. Global Preclinical Imaging Sales (K Units) by Application (2025-2030)
Table 62. Global Preclinical Imaging Sales Market Share by Application (2019-2024)
Table 63. Global Preclinical Imaging Sales Market Share by Application (2025-2030)
Table 64. Global Preclinical Imaging Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Preclinical Imaging Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Preclinical Imaging Revenue Market Share by Application (2019-2024)
Table 67. Global Preclinical Imaging Revenue Market Share by Application (2025-2030)
Table 68. Global Preclinical Imaging Price (USD/Unit) by Application (2019-2024)
Table 69. Global Preclinical Imaging Price (USD/Unit) by Application (2025-2030)
Table 70. Perkinelmer Corporation Information
Table 71. Perkinelmer Description and Business Overview
Table 72. Perkinelmer Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Perkinelmer Preclinical Imaging Product
Table 74. Perkinelmer Recent Developments/Updates
Table 75. Bruker Corporation Information
Table 76. Bruker Description and Business Overview
Table 77. Bruker Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Bruker Preclinical Imaging Product
Table 79. Bruker Recent Developments/Updates
Table 80. Fujifilm Corporation Information
Table 81. Fujifilm Description and Business Overview
Table 82. Fujifilm Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Fujifilm Preclinical Imaging Product
Table 84. Fujifilm Recent Developments/Updates
Table 85. Mediso Corporation Information
Table 86. Mediso Description and Business Overview
Table 87. Mediso Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Mediso Preclinical Imaging Product
Table 89. Mediso Recent Developments/Updates
Table 90. Milabs Corporation Information
Table 91. Milabs Description and Business Overview
Table 92. Milabs Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Milabs Preclinical Imaging Product
Table 94. Milabs Recent Developments/Updates
Table 95. MR Solutions Corporation Information
Table 96. MR Solutions Description and Business Overview
Table 97. MR Solutions Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. MR Solutions Preclinical Imaging Product
Table 99. MR Solutions Recent Developments/Updates
Table 100. Aspect Imaging Corporation Information
Table 101. Aspect Imaging Description and Business Overview
Table 102. Aspect Imaging Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Aspect Imaging Preclinical Imaging Product
Table 104. Aspect Imaging Recent Developments/Updates
Table 105. Li-Cor Biosciences Corporation Information
Table 106. Li-Cor Biosciences Description and Business Overview
Table 107. Li-Cor Biosciences Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Li-Cor Biosciences Preclinical Imaging Product
Table 109. Li-Cor Biosciences Recent Developments/Updates
Table 110. Trifoil Imaging Corporation Information
Table 111. Trifoil Imaging Description and Business Overview
Table 112. Trifoil Imaging Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Trifoil Imaging Preclinical Imaging Product
Table 114. Trifoil Imaging Recent Developments/Updates
Table 115. Miltenyi Biotec Corporation Information
Table 116. Miltenyi Biotec Description and Business Overview
Table 117. Miltenyi Biotec Preclinical Imaging Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Miltenyi Biotec Preclinical Imaging Product
Table 119. Miltenyi Biotec Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Preclinical Imaging Distributors List
Table 123. Preclinical Imaging Customers List
Table 124. Preclinical Imaging Market Trends
Table 125. Preclinical Imaging Market Drivers
Table 126. Preclinical Imaging Market Challenges
Table 127. Preclinical Imaging Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Preclinical Imaging
Figure 2. Global Preclinical Imaging Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Preclinical Imaging Market Share by Type in 2023 & 2030
Figure 4. Optical Imaging Systems Product Picture
Figure 5. Nuclear Imaging Systems Product Picture
Figure 6. Micro-MRI Systems Product Picture
Figure 7. Micro-Ultrasound Systems Product Picture
Figure 8. Micro-CT Systems Product Picture
Figure 9. Preclinical Photoacoustic Imaging Systems Product Picture
Figure 10. Preclinical Magnetic Particle Imaging (MPI) Systems Product Picture
Figure 11. Global Preclinical Imaging Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Preclinical Imaging Market Share by Application in 2023 & 2030
Figure 13. Hospitals
Figure 14. Diagnostics Centers
Figure 15. Others
Figure 16. Global Preclinical Imaging Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Preclinical Imaging Market Size (2019-2030) & (US$ Million)
Figure 18. Global Preclinical Imaging Sales (2019-2030) & (K Units)
Figure 19. Global Preclinical Imaging Average Price (USD/Unit) & (2019-2030)
Figure 20. Preclinical Imaging Report Years Considered
Figure 21. Preclinical Imaging Sales Share by Manufacturers in 2023
Figure 22. Global Preclinical Imaging Revenue Share by Manufacturers in 2023
Figure 23. The Global 5 and 10 Largest Preclinical Imaging Players: Market Share by Revenue in 2023
Figure 24. Preclinical Imaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 25. Global Preclinical Imaging Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 26. North America Preclinical Imaging Sales Market Share by Country (2019-2030)
Figure 27. North America Preclinical Imaging Revenue Market Share by Country (2019-2030)
Figure 28. U.S. Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Canada Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Europe Preclinical Imaging Sales Market Share by Country (2019-2030)
Figure 31. Europe Preclinical Imaging Revenue Market Share by Country (2019-2030)
Figure 32. Germany Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. France Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. U.K. Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Italy Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Russia Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Preclinical Imaging Sales Market Share by Region (2019-2030)
Figure 38. Asia Pacific Preclinical Imaging Revenue Market Share by Region (2019-2030)
Figure 39. China Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Japan Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. South Korea Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. India Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Taiwan Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Indonesia Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Thailand Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Malaysia Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Philippines Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Latin America Preclinical Imaging Sales Market Share by Country (2019-2030)
Figure 50. Latin America Preclinical Imaging Revenue Market Share by Country (2019-2030)
Figure 51. Mexico Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Brazil Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Argentina Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Middle East & Africa Preclinical Imaging Sales Market Share by Country (2019-2030)
Figure 55. Middle East & Africa Preclinical Imaging Revenue Market Share by Country (2019-2030)
Figure 56. Turkey Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. Saudi Arabia Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. U.A.E Preclinical Imaging Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 59. Global Sales Market Share of Preclinical Imaging by Type (2019-2030)
Figure 60. Global Revenue Market Share of Preclinical Imaging by Type (2019-2030)
Figure 61. Global Preclinical Imaging Price (USD/Unit) by Type (2019-2030)
Figure 62. Global Sales Market Share of Preclinical Imaging by Application (2019-2030)
Figure 63. Global Revenue Market Share of Preclinical Imaging by Application (2019-2030)
Figure 64. Global Preclinical Imaging Price (USD/Unit) by Application (2019-2030)
Figure 65. Preclinical Imaging Value Chain
Figure 66. Preclinical Imaging Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
